Ra Capital Management, L.P. Verona Pharma PLC Transaction History

Ra Capital Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$11.94 - $20.47 $75.4 Million - $129 Million	6,317,990 New	6,317,990 $126 Million
Q4 2022 Feb 14, 2023	BUY	$9.84 - $26.13 $2.64 Million - $7 Million	267,990 Added 4.43%	6,317,990 $165 Million
Q3 2022 Nov 14, 2022	BUY	$4.14 - $13.59 $3.93 Million - $12.9 Million	950,000 Added 18.63%	6,050,000 $61.8 Million
Q3 2020 Nov 16, 2020	BUY	$4.45 - $10.2 $22.7 Million - $52 Million	5,100,000 New	5,100,000 $31.8 Million

117

60.7M

139K

67.8K

Ticker VRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,954,200
Market Cap $736M
Description
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Ra Capital Management, L.P. with notifications on news.